Poly(methyl vinyl ether-co-maleic anhydride) nanoparticles as innate immune system activators

Adjuvant research is being oriented to TLR-agonists, but complement activation has been relatively unexplored. In previous studies it was demonstrated that poly(methyl vinyl ether-co-maleic anhydride) nanoparticles (PVMA NPs) used as adjuvant differentially activate dendritic cells through toll like...

Full description

Bibliographic Details
Main Authors: Camacho, A.I. (A.I.), Raquel, Tamayo, I. (Ibai), Souza, J. (Juliana) de, Lasarte, J.J. (Juan José), Mansilla, C. (Cristina), Esparza, I. (Irene), Irache, J.M. (Juan Manuel), Gamazo, C. (Carlos)
Format: info:eu-repo/semantics/article
Language:eng
Published: Elsevier 2011
Subjects:
Online Access:https://hdl.handle.net/10171/20362
_version_ 1793400146427379712
author Camacho, A.I. (A.I.)
Raquel
Tamayo, I. (Ibai)
Souza, J. (Juliana) de
Lasarte, J.J. (Juan José)
Mansilla, C. (Cristina)
Esparza, I. (Irene)
Irache, J.M. (Juan Manuel)
Gamazo, C. (Carlos)
author_facet Camacho, A.I. (A.I.)
Raquel
Tamayo, I. (Ibai)
Souza, J. (Juliana) de
Lasarte, J.J. (Juan José)
Mansilla, C. (Cristina)
Esparza, I. (Irene)
Irache, J.M. (Juan Manuel)
Gamazo, C. (Carlos)
author_sort Camacho, A.I. (A.I.)
collection DSpace
description Adjuvant research is being oriented to TLR-agonists, but complement activation has been relatively unexplored. In previous studies it was demonstrated that poly(methyl vinyl ether-co-maleic anhydride) nanoparticles (PVMA NPs) used as adjuvant differentially activate dendritic cells through toll like receptors (TLR) stimulation, however, a high dose of these NPs was used. Now, we demonstrated a dose-response effect, with a concentration as low as 20μg/mL able to stimulate TLR2 and TLR4 transfected dendritic cells. In addition, we investigated whether PVMA NPs are able to exploit also the immunomodulatory benefits of complement activation. Results indicated that the hydroxylated surface of these NPs highly activated the complement cascade, as measured by adsorption studies and a complement fixation bioassay. Stable binding of C3b to NPs was confirmed as indicated by lability to SDS treatment after washing resistance. Complement consumption was confirmed as the lytic capacity of complement exposed to NPs was abolished against antibody-sensitized sheep erythrocytes, with a minimal inhibitory concentration of 50μg NPs, equivalent to a surface of 1cm(2). On the contrary, nanoparticles prepared with poly(lactic-co-glycolic acid) (PLGA), used as a reference, did not consume complement at a concentration ≥3mg NPs (≥40cm(2)). Complement consumption was inhibited when PVMA NPs were cross-linked with diamino groups (1,3-diaminopropane), indicating the role of hydroxyl groups as responsible of the phenomenon. These results favour a model whereby PVMA NPs adjuvant activate complement on site to attract immature antigen presenting cells that are activated through TLR2 and TLR4.
format info:eu-repo/semantics/article
id oai:dadun.unav.edu:10171-20362
institution Universidad de Navarra
language eng
publishDate 2011
publisher Elsevier
record_format dspace
spelling oai:dadun.unav.edu:10171-203622022-11-28T11:33:53Z Poly(methyl vinyl ether-co-maleic anhydride) nanoparticles as innate immune system activators Camacho, A.I. (A.I.) Raquel Tamayo, I. (Ibai) Souza, J. (Juliana) de Lasarte, J.J. (Juan José) Mansilla, C. (Cristina) Esparza, I. (Irene) Irache, J.M. (Juan Manuel) Gamazo, C. (Carlos) Nanoparticles Adjuvant TLR- agonist Complement activation Adjuvant research is being oriented to TLR-agonists, but complement activation has been relatively unexplored. In previous studies it was demonstrated that poly(methyl vinyl ether-co-maleic anhydride) nanoparticles (PVMA NPs) used as adjuvant differentially activate dendritic cells through toll like receptors (TLR) stimulation, however, a high dose of these NPs was used. Now, we demonstrated a dose-response effect, with a concentration as low as 20μg/mL able to stimulate TLR2 and TLR4 transfected dendritic cells. In addition, we investigated whether PVMA NPs are able to exploit also the immunomodulatory benefits of complement activation. Results indicated that the hydroxylated surface of these NPs highly activated the complement cascade, as measured by adsorption studies and a complement fixation bioassay. Stable binding of C3b to NPs was confirmed as indicated by lability to SDS treatment after washing resistance. Complement consumption was confirmed as the lytic capacity of complement exposed to NPs was abolished against antibody-sensitized sheep erythrocytes, with a minimal inhibitory concentration of 50μg NPs, equivalent to a surface of 1cm(2). On the contrary, nanoparticles prepared with poly(lactic-co-glycolic acid) (PLGA), used as a reference, did not consume complement at a concentration ≥3mg NPs (≥40cm(2)). Complement consumption was inhibited when PVMA NPs were cross-linked with diamino groups (1,3-diaminopropane), indicating the role of hydroxyl groups as responsible of the phenomenon. These results favour a model whereby PVMA NPs adjuvant activate complement on site to attract immature antigen presenting cells that are activated through TLR2 and TLR4. 2011-12-22T13:52:45Z 2011-12-22T13:52:45Z 2011 info:eu-repo/semantics/article https://hdl.handle.net/10171/20362 eng info:eu-repo/semantics/openAccess application/pdf Elsevier
spellingShingle Nanoparticles
Adjuvant
TLR- agonist
Complement activation
Camacho, A.I. (A.I.)
Raquel
Tamayo, I. (Ibai)
Souza, J. (Juliana) de
Lasarte, J.J. (Juan José)
Mansilla, C. (Cristina)
Esparza, I. (Irene)
Irache, J.M. (Juan Manuel)
Gamazo, C. (Carlos)
Poly(methyl vinyl ether-co-maleic anhydride) nanoparticles as innate immune system activators
title Poly(methyl vinyl ether-co-maleic anhydride) nanoparticles as innate immune system activators
title_full Poly(methyl vinyl ether-co-maleic anhydride) nanoparticles as innate immune system activators
title_fullStr Poly(methyl vinyl ether-co-maleic anhydride) nanoparticles as innate immune system activators
title_full_unstemmed Poly(methyl vinyl ether-co-maleic anhydride) nanoparticles as innate immune system activators
title_short Poly(methyl vinyl ether-co-maleic anhydride) nanoparticles as innate immune system activators
title_sort poly(methyl vinyl ether-co-maleic anhydride) nanoparticles as innate immune system activators
topic Nanoparticles
Adjuvant
TLR- agonist
Complement activation
url https://hdl.handle.net/10171/20362
work_keys_str_mv AT camachoaiai polymethylvinylethercomaleicanhydridenanoparticlesasinnateimmunesystemactivators
AT raquel polymethylvinylethercomaleicanhydridenanoparticlesasinnateimmunesystemactivators
AT tamayoiibai polymethylvinylethercomaleicanhydridenanoparticlesasinnateimmunesystemactivators
AT souzajjulianade polymethylvinylethercomaleicanhydridenanoparticlesasinnateimmunesystemactivators
AT lasartejjjuanjose polymethylvinylethercomaleicanhydridenanoparticlesasinnateimmunesystemactivators
AT mansillaccristina polymethylvinylethercomaleicanhydridenanoparticlesasinnateimmunesystemactivators
AT esparzaiirene polymethylvinylethercomaleicanhydridenanoparticlesasinnateimmunesystemactivators
AT irachejmjuanmanuel polymethylvinylethercomaleicanhydridenanoparticlesasinnateimmunesystemactivators
AT gamazoccarlos polymethylvinylethercomaleicanhydridenanoparticlesasinnateimmunesystemactivators